445 related articles for article (PubMed ID: 25746089)
1. Sui generis: gene therapy and delivery systems for the treatment of glioblastoma.
Kane JR; Miska J; Young JS; Kanojia D; Kim JW; Lesniak MS
Neuro Oncol; 2015 Mar; 17 Suppl 2(Suppl 2):ii24-ii36. PubMed ID: 25746089
[TBL] [Abstract][Full Text] [Related]
2. Gene Delivery in Neuro-Oncology.
Dixit K; Kumthekar P
Curr Oncol Rep; 2017 Sep; 19(11):69. PubMed ID: 28866732
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy for glioblastoma: future perspective for delivery systems and molecular targets.
Shir A; Levitzki A
Cell Mol Neurobiol; 2001 Dec; 21(6):645-56. PubMed ID: 12043839
[No Abstract] [Full Text] [Related]
4. Systemic AAV9-IFNβ gene delivery treats highly invasive glioblastoma.
GuhaSarkar D; Su Q; Gao G; Sena-Esteves M
Neuro Oncol; 2016 Nov; 18(11):1508-1518. PubMed ID: 27194146
[TBL] [Abstract][Full Text] [Related]
5. Gene therapeutics: the future of brain tumor therapy?
Cutter JL; Kurozumi K; Chiocca EA; Kaur B
Expert Rev Anticancer Ther; 2006 Jul; 6(7):1053-64. PubMed ID: 16831077
[TBL] [Abstract][Full Text] [Related]
6. Current status of gene therapy for brain tumors.
Murphy AM; Rabkin SD
Transl Res; 2013 Apr; 161(4):339-54. PubMed ID: 23246627
[TBL] [Abstract][Full Text] [Related]
7. Viral and other therapies for recurrent glioblastoma: is a 24-month durable response unusual?
Chiocca EA; Nassiri F; Wang J; Peruzzi P; Zadeh G
Neuro Oncol; 2019 Jan; 21(1):14-25. PubMed ID: 30346600
[TBL] [Abstract][Full Text] [Related]
8. Viral-mediated gene transfer for cancer treatment.
Wilson DR
Curr Pharm Biotechnol; 2002 Jun; 3(2):151-64. PubMed ID: 12022258
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy and virotherapy: novel therapeutic approaches for brain tumors.
Kroeger KM; Muhammad AK; Baker GJ; Assi H; Wibowo MK; Xiong W; Yagiz K; Candolfi M; Lowenstein PR; Castro MG
Discov Med; 2010 Oct; 10(53):293-304. PubMed ID: 21034670
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy for glioblastoma.
Aghi M; Chiocca EA
Neurosurg Focus; 2006 Apr; 20(4):E18. PubMed ID: 16709023
[TBL] [Abstract][Full Text] [Related]
11. Immune and viral therapies for malignant primary brain tumors.
Gardeck AM; Sheehan J; Low WC
Expert Opin Biol Ther; 2017 Apr; 17(4):457-474. PubMed ID: 28274139
[TBL] [Abstract][Full Text] [Related]
12. Viral vector: potential therapeutic for glioblastoma multiforme.
Manikandan C; Kaushik A; Sen D
Cancer Gene Ther; 2020 May; 27(5):270-279. PubMed ID: 31316136
[TBL] [Abstract][Full Text] [Related]
13. A gene delivery system with a human artificial chromosome vector based on migration of mesenchymal stem cells towards human glioblastoma HTB14 cells.
Kinoshita Y; Kamitani H; Mamun MH; Wasita B; Kazuki Y; Hiratsuka M; Oshimura M; Watanabe T
Neurol Res; 2010 May; 32(4):429-37. PubMed ID: 19589205
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen improves cytopathic effect of oncolytic adenovirus in primary glioblastoma cells mediated through autophagy.
Ulasov IV; Shah N; Kaverina NV; Lee H; Lin B; Lieber A; Kadagidze ZG; Yoon JG; Schroeder B; Hothi P; Ghosh D; Baryshnikov AY; Cobbs CS
Oncotarget; 2015 Feb; 6(6):3977-87. PubMed ID: 25738357
[TBL] [Abstract][Full Text] [Related]
15. Glioma virus therapies between bench and bedside.
Kaufmann JK; Chiocca EA
Neuro Oncol; 2014 Mar; 16(3):334-51. PubMed ID: 24470549
[TBL] [Abstract][Full Text] [Related]
16. Molecular Targets and Nanoparticulate Systems Designed for the Improved Therapeutic Intervention in Glioblastoma Multiforme.
Akhter MH; Rizwanullah M; Ahmad J; Amin S; Ahmad MZ; Minhaj MA; Mujtaba MA; Ali J
Drug Res (Stuttg); 2021 Mar; 71(3):122-137. PubMed ID: 33167048
[TBL] [Abstract][Full Text] [Related]
17. Current status of immunotherapy and gene therapy for high-grade gliomas.
Marsh JC; Goldfarb J; Shafman TD; Diaz AZ
Cancer Control; 2013 Jan; 20(1):43-8. PubMed ID: 23302906
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy for human glioblastoma using neurotropic JC virus-like particles as a gene delivery vector.
Chao CN; Yang YH; Wu MS; Chou MC; Fang CY; Lin MC; Tai CK; Shen CH; Chen PL; Chang D; Wang M
Sci Rep; 2018 Feb; 8(1):2213. PubMed ID: 29396437
[TBL] [Abstract][Full Text] [Related]
19. Small interfering RNA (siRNA) to target genes and molecular pathways in glioblastoma therapy: Current status with an emphasis on delivery systems.
Mirzaei S; Mahabady MK; Zabolian A; Abbaspour A; Fallahzadeh P; Noori M; Hashemi F; Hushmandi K; Daneshi S; Kumar AP; Aref AR; Samarghandian S; Makvandi P; Khan H; Hamblin MR; Ashrafizadeh M; Zarrabi A
Life Sci; 2021 Jun; 275():119368. PubMed ID: 33741417
[TBL] [Abstract][Full Text] [Related]
20. Oncolytic adenoviral therapy for glioblastoma multiforme.
Sonabend AM; Ulasov IV; Han Y; Lesniak MS
Neurosurg Focus; 2006 Apr; 20(4):E19. PubMed ID: 16709024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
